全球颅内支架市场规模、份额、趋势和成长分析报告（2026-2034年）

预计颅内支架市场规模将从 2025 年的 30.9 亿美元成长到 2034 年的 51.2 亿美元，2026 年至 2034 年的复合年增长率为 5.78%。

由于脑血管疾病（例如动脉瘤和狭窄）的发生率不断上升，颅内支架市场正经历显着增长。随着世界人口老化和影响脑部血流的疾病发生率增加，对有效治疗方法的需求也日益增长。颅内支架透过支撑血管和改善血流，成为治疗这些疾病的重要工具。支架设计的创新，包括生物可吸收支架和药物释放型支架的研发，提高了这些器械的疗效和安全性，使其成为医疗机构和患者更具吸引力的选择。

此外，微创技术的进步正在改变颅内支架市场。血管内手术的广泛应用，使得支架可以透过微小切口植入，从而缩短了患者的恢復时间，并改善了治疗效果。随着医疗专业人员积极采用这些技术，对即使在解剖结构复杂的情况下也能有效植入的先进颅内支架的需求预计将会增加。此外，术中血管造影术和三维成像等影像技术的整合提高了支架植入的精确度，进一步推动了市场成长。

此外，神经病学领域研发投入的不断增加正在推动颅内支架市场的创新。学术机构、研究组织和医疗设备製造商之间的合作正在推动新一代支架的研发，以应对当前挑战并改善患者照护。人们对脑血管疾病的认识不断提高，以及对早期疗育重要性的理解，也促进了市场的扩张。总之，颅内支架市场预计将迎来强劲成长，其特点是技术进步、注重微创手术以及致力于改善脑血管疾病患者的治疗效果。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 绘製渗透率和成长前景图
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场问题
• 波特五力分析
• PESTLE分析

4. 全球颅内支架市场（依产品类型划分）

• 市场分析、洞察与预测
• 自动扩张型支架
• 球囊扩张支架
• 支架辅助弹簧圈栓塞术

5. 全球颅内支架市场（依适应症划分）

• 市场分析、洞察与预测
• 颅内狭窄
• 脑动脉瘤

6. 全球颅内支架市场（依最终用户划分）

• 市场分析、洞察与预测
• 医院
• 门诊手术中心
• 其他的

7. 全球颅内支架市场（依地区划分）

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商格局（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Penumbra Inc
  • Medtronic
  • Stryker Corporation
  • Boston Scientific Corporation
  • Johnson & Johnson Services Inc
  • Cook Medical
  • Acandis
  • Penumbra, Inc
  • MicroPort Scientific
  • Phenox
  • Terumo Corporation

The Intracranial Stents Market size is expected to reach USD 5.12 Billion in 2034 from USD 3.09 Billion (2025) growing at a CAGR of 5.78% during 2026-2034.

The intracranial stents market is experiencing significant growth, driven by the increasing prevalence of cerebrovascular diseases, such as aneurysms and stenosis. As the global population ages and the incidence of conditions that affect blood flow to the brain rises, the demand for effective treatment options is surging. Intracranial stents are essential tools in the management of these conditions, providing support to blood vessels and improving blood flow. Innovations in stent design, including the development of bioresorbable and drug-eluting stents, are enhancing the efficacy and safety of these devices, making them more appealing to healthcare providers and patients alike.

Moreover, advancements in minimally invasive techniques are transforming the intracranial stents market. The rise of endovascular procedures, which allow for the placement of stents through small incisions, is reducing recovery times and improving patient outcomes. As healthcare providers increasingly adopt these techniques, the demand for advanced intracranial stents that can be deployed effectively in challenging anatomical locations is expected to grow. Additionally, the integration of imaging technologies, such as intraoperative angiography and 3D imaging, is enhancing the precision of stent placement, further driving market growth.

Furthermore, the increasing focus on research and development in the field of neurology is fostering innovation in the intracranial stents market. Collaborations between academic institutions, research organizations, and medical device manufacturers are leading to the development of next-generation stents that address current limitations and improve patient care. The growing awareness of cerebrovascular diseases and the importance of early intervention is also contributing to the expansion of the market. In summary, the intracranial stents market is set for robust growth, characterized by technological advancements, a focus on minimally invasive procedures, and a commitment to improving patient outcomes in the management of cerebrovascular conditions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Self-Expanding Stents
• Balloon Expanding Stents
• Stent-Assisted Coil Embolization

By Disease Indication

• Intracranial Stenosis
• Brain Aneurysm

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• Penumbra Inc, Medtronic, Stryker Corporation, Boston Scientific Corporation, Johnson Johnson Services Inc, Cook Medical, Acandis, Penumbra, Inc, MicroPort Scientific, Phenox, Terumo Corporation

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL INTRACRANIAL STENTS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Self-Expanding Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Balloon Expanding Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Stent-Assisted Coil Embolization Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INTRACRANIAL STENTS MARKET: BY DISEASE INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Disease Indication
• 5.2. Intracranial Stenosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Brain Aneurysm Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INTRACRANIAL STENTS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INTRACRANIAL STENTS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Disease Indication
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Disease Indication
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Disease Indication
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Disease Indication
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Disease Indication
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL INTRACRANIAL STENTS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Penumbra Inc
  • 9.2.2 Medtronic
  • 9.2.3 Stryker Corporation
  • 9.2.4 Boston Scientific Corporation
  • 9.2.5 Johnson & Johnson Services Inc
  • 9.2.6 Cook Medical
  • 9.2.7 Acandis
  • 9.2.8 Penumbra, Inc
  • 9.2.9 MicroPort Scientific
  • 9.2.10 Phenox
  • 9.2.11 Terumo Corporation